Development asset linked to Gan & Lee in public FDA and regional records.
pharma · Type 2 Diabetes Mellitus (T2DM)
Gan & Lee
Gan & Lee Pharmaceuticals.
Gan & Lee drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
1998 Founded
494 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Founded
- 1998
- Employees
- 494
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Gan & Lee pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Gan & Lee drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.